PACKAGING OF HEPATITIS B SURFACE ANTIGEN VACCINE AND MORINGA OLEIFERA EXTRACT INTO CHITOSAN NANOPARTICLES

Journal Title: Asian Journal of Pharamceutical and Clinical Research - Year 2019, Vol 12, Issue 1

Abstract

Objective: Oftentimes, the recombinant antigen for the use of vaccines is less immunogenic than live attenuated or inactive vaccines. Hence, a potent adjuvant is needed to enhance the immune response. Moreover, the role of vector design is also important to facilitate the improvement of the immune response. The aim of this research was to develop hepatitis B surface antigen (HBsAg)-loaded nanoparticles and Moringa oleifera aqueous leaf extracts as an adjuvant using chitosan polymer. Methods: Chitosan nanoparticles were prepared by the ionic gelation method using sodium tripolyphosphate as the cross-linking agent. A system was composed of chitosan core in which HBsAg and M. oleifera extracts were incorporated. The concentration of HBsAg used in this combination was 10 μg/ml, and the concentrations of extracts were 10, 50, and 100 μg/ml, respectively. In this study, three types of nanoparticles were produced: HBsAg-loaded nanoparticles, M. oleifera-loaded nanoparticles, and combination of HBsAg–M. oleifera-loaded nanoparticles. The nanoparticles formed were characterized by the particle size, HBsAg entrapment efficiency using sodium dodecyl sulfate polyacrylamide gel electrophoresis, and the entrapment efficiency of extracts using the total flavonoid method. Results: The results showed that the particle size was between 111 and 245 nm. The entrapment efficiency of HBsAg in the separate formula was 79%, while that in the combined formula was approximately 96–98%. Furthermore, the entrapment efficiency of the extracts in the separate formula was around 64–91%, while that in the combined formula was 55–82.5%. Particularly, HBsAg–M. oleifera-loaded chitosan nanoparticles with the extract concentrations of 50 μg/ml showed the highest entrapment efficiencies of HBsAg and M. oleifera extracts of approximately 98 and 82.5%, respectively. Conclusion: Collectively, the system has been successfully developed, so it is then plausible to determine the function of the devices to enhance the immune response in the future.

Authors and Affiliations

Diky Mudhakir, Adik Ahmadi, Muhamad Insanu, Neny Nuraini

Keywords

Related Articles

A STUDY ON UTILIZATION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS IN PATIENTS WITH CARDIOVASCULAR DISEASES

Objectives: The objective of this study was to assess the prescribing pattern, most common indication, and adverse effects associated with angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blocker...

Safety evaluation of petroleum ether, acetone, and hydroalcoholic extracts of Holoptelea integrifolia by oral administration in Wistar rats

 Objective: There are no reports on safety information of Holoptelea integrifolia (Roxb.) Planch. bark extracts by oral administration for long duration.This study is planned to add information on the safety margin of H...

PHOTO-ASSISTED DEGRADATION OF 3-MERCAPTOPROPIONIC ACID BY FENTON REAGENT

ABSTRACTObjectives: The main objective of the research were to develop an energy saver, cheaper eco-friendly method for removal of pollutants, becauseanother process needing a large consumption of energy, time and produc...

PRESCRIPTION WRITING PRACTICES AND ERRORS IN PRESCRIPTIONS CONTAINING CARDIOVASCULAR DRUGS ESPECIALLY ACE INHIBITORS IN KARACHI, PAKISTAN

ABSTRACTObjective: This is the first study related to the prescribing errors in cardiovascular prescription drugs especially Angiotensin converting enzymeinhibitors (ACEIs) conducted with the aim to identify the prescrib...

SEIZURES WITH ANTI-SEIZURE DRUG

This case study is to report and explore the etiology of a case of refractory seizures due to overdosage of phenytoin tablets. A case report from the Department of Neurology generated through voluntary adverse drug react...

Download PDF file
  • EP ID EP607159
  • DOI 10.22159/ajpcr.2019.v12i1.15386
  • Views 140
  • Downloads 0

How To Cite

Diky Mudhakir, Adik Ahmadi, Muhamad Insanu, Neny Nuraini (2019). PACKAGING OF HEPATITIS B SURFACE ANTIGEN VACCINE AND MORINGA OLEIFERA EXTRACT INTO CHITOSAN NANOPARTICLES. Asian Journal of Pharamceutical and Clinical Research, 12(1), 346-350. https://europub.co.uk/articles/-A-607159